|
CA2414421A1
(en)
|
2000-07-31 |
2002-02-07 |
Gene Logic, Inc. |
Molecular toxicology modeling
|
|
WO2002022163A1
(en)
*
|
2000-09-13 |
2002-03-21 |
Chugai Seiyaku Kabushiki Kaisha |
Remedies for ischemic diseases
|
|
JP2004519222A
(ja)
*
|
2000-12-07 |
2004-07-02 |
ジヤンセル・エス・アー |
Ｃａｒｐ遺伝子の上流配列、それらを含むベクターとその使用
|
|
US20050124568A1
(en)
|
2001-05-18 |
2005-06-09 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of acetyl-CoA-carboxylase gene expression using short interfering nucleic acid (siNA)
|
|
US6964950B2
(en)
*
|
2001-07-25 |
2005-11-15 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of C-reactive protein expression
|
|
EP2447370B1
(en)
|
2001-09-28 |
2018-07-18 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
MicroRNA molecules
|
|
AU2003219713A1
(en)
|
2002-02-04 |
2003-09-02 |
Gene Logic, Inc. |
Primary rat hepatocyte toxicity modeling
|
|
US20080214437A1
(en)
|
2002-09-06 |
2008-09-04 |
Mohapatra Shyam S |
Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
|
|
US7781415B2
(en)
|
2003-02-07 |
2010-08-24 |
Roche Madison Inc. |
Process for delivering sirna to cardiac muscle tissue
|
|
US7683036B2
(en)
|
2003-07-31 |
2010-03-23 |
Regulus Therapeutics Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
|
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
WO2005017145A1
(ja)
|
2003-08-13 |
2005-02-24 |
Japan Biological Informatics Consortium |
機能性ｒｎａが制御する被制御遺伝子の同定・予測方法及びその利用方法
|
|
US20050256072A1
(en)
|
2004-02-09 |
2005-11-17 |
University Of Massachusetts |
Dual functional oligonucleotides for use in repressing mutant gene expression
|
|
CA2554818A1
(en)
|
2004-02-09 |
2005-08-25 |
Thomas Jefferson University |
Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
|
|
EP1723162A4
(en)
|
2004-02-13 |
2010-05-05 |
Univ Rockefeller |
ANTI-microRNA oligonucleotide molecules
|
|
EP2290073A3
(en)
|
2004-05-28 |
2011-08-31 |
Asuragen, Inc. |
Methods and compositions involving microRNA
|
|
US7635563B2
(en)
|
2004-06-30 |
2009-12-22 |
Massachusetts Institute Of Technology |
High throughput methods relating to microRNA expression analysis
|
|
WO2006013561A2
(en)
|
2004-08-02 |
2006-02-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions and methods for diagnosing and treating post traumatic stress disorder
|
|
JP2006101790A
(ja)
|
2004-10-06 |
2006-04-20 |
Japan Health Science Foundation |
高血圧症のリスクの評価方法
|
|
US20080269072A1
(en)
|
2004-10-21 |
2008-10-30 |
Hart Ronald P |
Rational Probe Optimization for Detection of MicroRNAs
|
|
EP2302055B1
(en)
*
|
2004-11-12 |
2014-08-27 |
Asuragen, Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
|
WO2006063356A1
(en)
|
2004-12-10 |
2006-06-15 |
Isis Phamaceuticals, Inc. |
Regulation of epigenetic control of gene expression
|
|
US20060185027A1
(en)
|
2004-12-23 |
2006-08-17 |
David Bartel |
Systems and methods for identifying miRNA targets and for altering miRNA and target expression
|
|
EP1838870A2
(en)
|
2004-12-29 |
2007-10-03 |
Exiqon A/S |
NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF MICRORNAS AND THEIR TARGET MRNAs
|
|
US8071306B2
(en)
|
2005-01-25 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Methods for quantitating small RNA molecules
|
|
CN101203611B
(zh)
|
2005-04-19 |
2013-08-14 |
巴斯福植物科学有限公司 |
控制基因表达的改良方法
|
|
CA2609142C
(en)
|
2005-05-27 |
2016-02-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Therapeutic gene vectors comprising mirna target sequences
|
|
WO2007035684A2
(en)
|
2005-09-16 |
2007-03-29 |
Primera Biosystems, Inc. |
Method for quantitative detection of short rna molecules
|
|
US20070092882A1
(en)
|
2005-10-21 |
2007-04-26 |
Hui Wang |
Analysis of microRNA
|
|
KR101485071B1
(ko)
|
2005-12-12 |
2015-01-26 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
마이크로 ｒｎａ를 이용한 근육 세포 증식 및 분화 조절방법과 근육 세포 치료방법 및 유전자 발현 억제방법그리고 마이크로 ｒｎａ 분자의 발현용 벡터와 이를 이용한키트 및 미오사이트
|
|
WO2007073737A1
(en)
|
2005-12-29 |
2007-07-05 |
Exiqon A/S |
Detection of tissue origin of cancer
|
|
AU2007211082B2
(en)
|
2006-01-27 |
2012-09-27 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for the use in modulation of microRNAs
|
|
EP2007888A2
(en)
|
2006-04-03 |
2008-12-31 |
Santaris Pharma A/S |
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
|
|
AU2007281261B2
(en)
*
|
2006-08-01 |
2013-03-21 |
Board Of Regents Of The University Of Texas System |
Identification of a micro-RNA that activates expression of beta-myosin heavy chain
|
|
US20090306181A1
(en)
|
2006-09-29 |
2009-12-10 |
Children's Medical Center Corporation |
Compositions and methods for evaluating and treating heart failure
|
|
EP2208798B1
(de)
|
2006-10-09 |
2013-08-07 |
Medizinische Hochschule Hannover |
MicroRNA (miRNA) zur Diagnose und Therapie von Herzerkrankungen
|
|
AU2007323469B2
(en)
|
2006-11-23 |
2014-07-24 |
Guangdong Maijinjia Biotechnology Co., Ltd |
Oligonucleotides for modulating target RNA activity
|
|
MX2009006310A
(es)
|
2006-12-14 |
2009-07-22 |
Novartis Ag |
Composiciones y metodos para tratar trastornos musculares y cardiovasculares.
|
|
EP3536788A1
(en)
|
2006-12-21 |
2019-09-11 |
QIAGEN GmbH |
Microrna target site blocking oligos and uses thereof
|
|
WO2008074328A2
(en)
|
2006-12-21 |
2008-06-26 |
Exiqon A/S |
Microrna target site blocking oligos and uses thereof
|
|
WO2008147837A1
(en)
|
2007-05-23 |
2008-12-04 |
Dharmacon, Inc. |
Micro-rna scaffolds, non-naturally occurring micro-rnas, and methods for optimizing non-naturally occurring micro-rnas
|
|
EP2187896B1
(en)
|
2007-07-31 |
2016-01-13 |
The Board of Regents of The University of Texas System |
Inhibitors of mir-499 and mir-208b for use in the treatment of pathologic cardiac hypertrophy, heart failure or myocardial infarction
|
|
US20100292099A1
(en)
|
2007-08-23 |
2010-11-18 |
Keren Pharmaceutical, Inc. |
Targeting of rna with external guide sequences
|
|
EP2623599B1
(en)
|
2007-10-04 |
2019-01-02 |
Roche Innovation Center Copenhagen A/S |
Micromirs
|
|
WO2009058818A2
(en)
|
2007-10-29 |
2009-05-07 |
The Board Of Regents Of The University Of Texas System |
Compositions comprising a micro-rna and methods of their use in regulating cardiac remodeling
|
|
KR20100099158A
(ko)
|
2007-11-09 |
2010-09-10 |
보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 |
심근세포 생존과 심장 회복을 제어하는 ＭＩＲ-15 집단의 마이크로ＲＮＡｓ
|
|
WO2009114681A2
(en)
|
2008-03-13 |
2009-09-17 |
Dharmacon, Inc. |
Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy
|
|
US20090326049A1
(en)
|
2008-04-04 |
2009-12-31 |
Alexander Aristarkhov |
Blocking oligos for inhibition of microrna and sirna activity and uses thereof
|
|
US8222221B2
(en)
|
2008-06-04 |
2012-07-17 |
The Board Of Regents Of The University Of Texas System |
Modulation of gene expression through endogenous small RNA targeting of gene promoters
|
|
EP2303292A4
(en)
|
2008-06-09 |
2013-01-02 |
New York Medical College |
COMPOSITIONS WITH CARDIAL STEM CELLS WITH OVEREXPRESSION OF SPECIFIC MICRORNAS AND METHOD FOR THEIR USE IN THE REPAIR OF THE CARED MYOCARDIC
|
|
EP2447274B1
(en)
|
2008-10-24 |
2017-10-04 |
Ionis Pharmaceuticals, Inc. |
Oligomeric compounds and methods
|